Caption Management, LLC Invitae Corp Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $188,980 - $398,959	110,515 Added 339.27%	143,089 $266,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $52,390 - $237,963	27,574 Added 551.48%	32,574 $80,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $9,129 - $38,616	4,286 Added 600.28%	5,000 $12,000
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $237,569 - $409,098	-7,186 Reduced 90.96%	714 $27,000
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $909,760 - $1.43 Million	-32,000 Reduced 80.2%	7,900 $343,000
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $386,430 - $999,570	33,000 Added 478.26%	39,900 $1.21 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $22,156 - $79,750	-2,900 Reduced 29.59%	6,900 $94,000
Q4 2019 Feb 13, 2020	SELL	$15.02 - $20.57 $231,368 - $316,860	-15,404 Reduced 61.12%	9,800 $159,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $475,095 - $693,110	25,204 New	25,204 $486,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.